Ian

Analyst

Cantor Fitzgerald

Equibles does not estimate personal net worth.

About Ian

Ian is recorded as Analyst at Cantor Fitzgerald. Ian has spoken on 2 earnings calls and 3 other investor events across 4 companies, most recently for Capricor Therapeutics, Inc. on November 10, 2026. Those appearances were for Alaska Air Group, Inc. (ALK), Capricor Therapeutics, Inc. (CAPR), Codexis, Inc. (CDXS) and Crane NXT, Co. (CXT). The companies whose calls Ian spoke on are classified in the Industrials and Healthcare sectors.

Ian on recent calls

“With the arbitration hearing expected to begin mid-2027 next year, I'm just wondering how you see this potentially impacting bringing Dara Myercell to market if approved later this month.”

Analyst — Cantor Fitzgerald, Capricor Therapeutics Third Quarter 2026 Financial Results and Corporate Update Conference Call · November 10, 2026

“Throughout Alaska Accelerate, you've heard us talk about unlocking the full value of Air Group. Cargo is a perfect example of that strategy in action. Historically, cargo has been a strong contributor to Alaska's performance.”

Alaska Air Group’s 2026 Investor Day · September 29, 2026

“Throughout Alaska Accelerate, you've heard us talk about unlocking the full value of Air Group. Cargo is a perfect example of that strategy in action. Historically, cargo has been a strong contributor to Alaska's performance.”

Alaska Air Group’s Investor Day · September 29, 2026

“Could you speak at a high level about the risks that are involved in scaling the platform from 100-gram scale to like 500-gram by year-end? And now that you're operating at 100-gram, what aspects of the scale-up process do you believe have been de-risked versus what remains to be proven?”

Analyst — Cantor Fitzgerald, Codexis, Inc. Q1 FY2026 Earnings Call · May 7, 2026